Mar. 19 at 7:41 PM
$EDAP I found this comment interesting from yesterday's Oppenheimer presentation - they are position for growth in both mens AND WOMENS healthcare. Where is the press release regarding the Endometriosis studies!!!! Shouldn't we have heard from these studies by now!!!
"We’re positioned for growth with large addressable markets now both in men’s and women’s health. We have a growing global install base of leading tier one academic and community hospitals with more sales coming each quarter. We have differentiated non-invasive robotic HIFU technology, which solves a notable unmet need for both prostate cancer, BPH, as well as endometriosis. We have a strong body of clinical evidence with favorable reimbursement in place, and a proven management team from industry-leading med tech companies such as Intuitive, Medtronic, Stryker, Boston Scientific, GE HealthCare, Johnson & Johnson, and others. Thank you."
